Elevated Levels of PFAS Detected in Umbilical Cord Blood, Raising Public Health Concerns

Robert Shaw, Health Correspondent
4 Min Read
⏱️ 3 min read

**

Recent research has revealed alarming findings regarding the prevalence of PFAS, commonly referred to as “forever chemicals,” in the umbilical cord blood of fetuses. A study conducted by Mount Sinai researchers discovered 42 different PFAS compounds in samples taken from 120 umbilical cords, indicating a far greater exposure than previously recognised. This significant revelation has raised urgent questions about the potential health implications for newborns and the effectiveness of current regulatory measures.

Uncovering the Extent of PFAS Exposure

Traditionally, testing of umbilical cord blood has focused on a limited set of PFAS compounds, specifically perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the comprehensive testing employed in the Mount Sinai study, termed “non-targeted analysis,” has unearthed a much wider array of these substances. Previous examinations had only detected up to four compounds in the samples, underscoring the limitations of conventional testing methods.

Shelley Liu, a co-author of the study and an associate professor at the Icahn School of Medicine, noted, “Babies are exposed to many more PFAS than we previously thought.” Given that this exposure occurs during a critical period of development, understanding its implications is paramount.

The Health Risks Associated with PFAS

PFAS comprises around 15,000 synthetic chemicals, renowned for their water-, stain-, and grease-resistant properties. However, their persistence in the environment—and consequently in human bodies—is troubling. These substances have been linked to severe health issues, including various cancers, birth defects, compromised immune responses, elevated cholesterol levels, and kidney disease.

The Health Risks Associated with PFAS

Fetuses are particularly vulnerable, as extensive reviews of over 30,000 umbilical cord blood samples have consistently detected PFAS. Elevated maternal levels of these compounds correlate with increased risks of infant mortality, low birth weight, and obesity in later life. Additionally, prenatal exposure to PFAS has been associated with long-term neurological and cardiovascular disorders.

Regulatory Shortcomings in PFAS Monitoring

Despite the rising concerns, current regulatory frameworks lag behind the emerging science. The U.S. Environmental Protection Agency (EPA) primarily tests for around 30 to 40 PFAS compounds in water, while researchers have identified thousands. The EPA’s recent certification of a blood test for 53 compounds marks a step forward, but it still falls short, as the Mount Sinai study identified 31 compounds not included in the EPA’s testing repertoire.

This disconnect highlights a critical gap in safeguarding public health, as insufficient monitoring could lead to underreported levels of PFAS exposure in the population.

Implications for Future Research and Policy

The implications of these findings extend beyond mere academic interest. The study’s blood samples were part of the federal government’s Home study, a long-term examination of PFAS exposure and its health outcomes. Researchers at Mount Sinai plan to delve deeper into understanding how these elevated PFAS levels might affect health over time.

Implications for Future Research and Policy

David Andrews, acting chief science officer at the Environmental Working Group, commented on the findings, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”

Why it Matters

The detection of higher-than-expected levels of PFAS in umbilical cord blood serves as a wake-up call regarding the urgent need for more stringent environmental regulations and improved public health protections. As these chemicals continue to permeate our environment and bodies, it is crucial for policymakers to respond with robust frameworks that prioritise the health of vulnerable populations, particularly pregnant individuals and their infants. The findings underscore the need for comprehensive testing and regulation to mitigate the exposure risks associated with these persistent pollutants.

Share This Article
Robert Shaw covers health with a focus on frontline NHS services, patient care, and health inequalities. A former healthcare administrator who retrained as a journalist at Cardiff University, he combines insider knowledge with investigative skills. His reporting on hospital waiting times and staff shortages has informed national health debates.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy